(Reuters) -Life sciences group Thermo Fisher is nearing an all-cash takeover of drug trial software maker Clario in a deal that could value the healthcare technology group at approximately $10 billion, the Financial Times reported on Tuesday.

Reuters could not immediately verify the report.

(Reporting by Ananya Palyekar in Bengaluru; Editing by Rashmi Aich)

See Full Page